PAPER Forlenza OV, Diniz BS, Radanovic M, Santos FS, Talib LL, Gattaz WF
SEARCH RESULTS
330026 RESULTS
PAPER Britton GB, Smith MA, Perry G, Sambamurti K, Jagannatha Rao KS
Drug discovery for neurodegenerative diseases: challenges and novel biochemical targets dedicated to the memory of Mark A. Smith for his inspiring contribution to Alzheimer's disease.
J Alzheimers Dis. 2011;24 Suppl 2:1-2. PubMed: 21525570PAPER Lambert JC, Dallongeville J, Ellis KA, Schraen-Maschke S, Lui J, Laws S, Dumont J, Richard F, Cottel D, Berr C, Ames D, Masters CL, Rowe CC, Szoeke C, Tzourio C, Dartigues JF, Buée L, Martins R, Amouyel P
Association of plasma Aß peptides with blood pressure in the elderly.
PLoS One. 2011;6(4):e18536. PubMed: 21525986PAPER Oghabian MA, Batouli SA, Norouzian M, Ziaei M, Sikaroodi H
Using functional Magnetic Resonance Imaging to differentiate between healthy aging subjects, Mild Cognitive Impairment, and Alzheimer's patients.
J Res Med Sci. 2010 Mar;15(2):84-93. PubMed: 21526064PAPER Tractenberg RE, Pietrzak RH
Intra-individual variability in Alzheimer's disease and cognitive aging: definitions, context, and effect sizes.
PLoS One. 2011;6(4):e16973. PubMed: 21526188PAPER Craig-Schapiro R, Kuhn M, Xiong C, Pickering EH, Liu J, Misko TP, Perrin RJ, Bales KR, Soares H, Fagan AM, Holtzman DM
Multiplexed immunoassay panel identifies novel CSF biomarkers for Alzheimer's disease diagnosis and prognosis.
PLoS One. 2011;6(4):e18850. PubMed: 21526197PAPER Kumar A, Bullard RL, Patel P, Paslay LC, Singh D, Bienkiewicz EA, Morgan SE, Rangachari V
Non-esterified fatty acids generate distinct low-molecular weight amyloid-β (Aβ42) oligomers along pathway different from fibril formation.
PLoS One. 2011;6(4):e18759. PubMed: 21526230PAPER Pomara N, Bruno D, Sidtis JJ
Plasma beta-amyloid level, cognitive reserve, and cognitive decline.
JAMA. 2011 Apr 27;305(16):1655; author reply 1655-6. PubMed: 21521842PAPER Reglodi D, Kiss P, Lubics A, Tamas A
Review on the protective effects of PACAP in models of neurodegenerative diseases in vitro and in vivo.
Curr Pharm Des. 2011;17(10):962-72. PubMed: 21524257PAPER Fuso A, Scarpa S
One-carbon metabolism and Alzheimer's disease: is it all a methylation matter?
Neurobiol Aging. 2011 Jul;32(7):1192-5. PubMed: 21524430PAPER McClean PL, Parthsarathy V, Faivre E, Hölscher C
The diabetes drug liraglutide prevents degenerative processes in a mouse model of Alzheimer's disease.
J Neurosci. 2011 Apr 27;31(17):6587-94. PubMed: 21525299PAPER Tang-Wai DF, Graff-Radford NR
Looking into posterior cortical atrophy: providing insight into Alzheimer disease.
Neurology. 2011 May 24;76(21):1778-9. PubMed: 21525423PAPER Rosenbloom MH, Alkalay A, Agarwal N, Baker SL, O'Neil JP, Janabi M, Yen IV, Growdon M, Jang J, Madison C, Mormino EC, Rosen HJ, Gorno-Tempini ML, Weiner MW, Miller BL, Jagust WJ, Rabinovici GD
Distinct clinical and metabolic deficits in PCA and AD are not related to amyloid distribution.
Neurology. 2011 May 24;76(21):1789-96. PubMed: 21525424PAPER Seguin J, Formaglio M, Perret-Liaudet A, Quadrio I, Tholance Y, Rouaud O, Thomas-Anterion C, Croisile B, Mollion H, Moreaud O, Salzmann M, Dorey A, Bataillard M, Coste MH, Vighetto A, Krolak-Salmon P
CSF biomarkers in posterior cortical atrophy.
Neurology. 2011 May 24;76(21):1782-8. PubMed: 21525425PAPER Galvin JE, Price JL, Yan Z, Morris JC, Sheline YI
Resting bold fMRI differentiates dementia with Lewy bodies vs Alzheimer disease.
Neurology. 2011 May 24;76(21):1797-803. PubMed: 21525427Current Filters
No filters selected